EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 50 / No 1 (March 2018) J Extra Corpor Technol, 50 1 (2018) 38-43 References
Free Access
Issue
J Extra Corpor Technol
Volume 50, Number 1, March 2018
Page(s) 38 - 43
DOI https://doi.org/10.1051/ject/201850038
Published online 15 March 2018
  1. Hattersley PG Activated coagulation time of whole blood. JAMA. 1966;196:436–40. [CrossRef] [PubMed] [Google Scholar]
  2. College of American Pathologists. Surveys 2010 CT1-A, Participant Survey. 2-5-14. Ref type: Report. [Google Scholar]
  3. Philipp A, Muller T, Bein T, et al. Inhibition of thrombocyte aggregation during extracorporeal lung assist: A case report. Perfusion. 2007;22:293–7. [CrossRef] [PubMed] [Google Scholar]
  4. Krill CEJr, Moquin RB Use of a modified activated clotting time of blood. Med Ann Dist Columbia. 1968;37:202–4. [PubMed] [Google Scholar]
  5. Verska JJ Control of heparinization by activated clotting time during bypass with improved postoperative hemostasis. Ann Thorac Surg. 1977;24:170–3. [CrossRef] [PubMed] [Google Scholar]
  6. Arkin CF, Shahsavari M, Copeland BE, et al. Evaluation of the activated clotting time to control heparin and protamine dosage in open-heart surgery. J Thorac Cardiovasc Surg. 1978;75:790–2. [CrossRef] [PubMed] [Google Scholar]
  7. Young JA, Kisker CT, Doty DB Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomer. Ann Thorac Surg. 1978;26:231–40. [CrossRef] [PubMed] [Google Scholar]
  8. Spinler SA, Wittkowsky AK, Nutescu EA, et al. Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin. Ann Pharmacother. 2005;39:1275–85. [CrossRef] [PubMed] [Google Scholar]
  9. Miles LF, Coulson TG, Galhardo C, et al. Pump priming practices and anticoagulation in cardiac surgery: Results from the global cardiopulmonary bypass survey. Anesth Analg. 2017;125:1871–7. [CrossRef] [PubMed] [Google Scholar]
  10. Hug MI, Di Bernardo S, Berger F, et al. Measurement of activated clotting time in children–comparison of the Celite i-STAT ACT with the Medtronic ACT II. Acta Anaesthesiol Scand. 2004;48:211–7. [CrossRef] [PubMed] [Google Scholar]
  11. Van Cott EM Coagulation point-of-care testing. Clin Lab Med. 2001;21:337–50. [CrossRef] [PubMed] [Google Scholar]
  12. Lewandrowski EL, Van Cott EM, Gregory K, et al. Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: Comparison with the Medtronic ACT Plus. Am J Clin Pathol. 2011;135:741–8. [CrossRef] [PubMed] [Google Scholar]
  13. Paniccia R, Fedi S, Carbonetto F, et al. Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. Anesthesiology. 2003;99:54–9. [CrossRef] [PubMed] [Google Scholar]
  14. Schussler JM, Aguanno JJ, Glover EN, et al. Comparison of the i-STAT handheld activated clotting time with the Hemochron activated clotting time during and after percutaneous coronary intervention. Am J Cardiol. 2003;91:464–6. [CrossRef] [PubMed] [Google Scholar]
  15. Schussler JM, Lander SR, Wissinger LA, et al. Validation of the i-STAT handheld activated clotting time for use with bivalirudin. Am J Cardiol. 2004;93:1318–9. [CrossRef] [PubMed] [Google Scholar]
  16. Ojito JW, Hannan RL, Burgos MM, et al. Comparison of point-of-care activated clotting time systems utilized in a single pediatric institution. J Extra Corpor Technol. 2012;44:15–20. [PubMed] [Google Scholar]
  17. Mochizuki T, Olson PJ, Szlam F, et al. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 1998;87:781–5. [CrossRef] [PubMed] [Google Scholar]
  18. Nybo M, Madsen JS Serious anaphylactic reactions due to protamine sulfate: A systematic literature review. Basic Clin Pharmacol Toxicol. 2008;103:192–6. [CrossRef] [PubMed] [Google Scholar]
  19. Koster A, Fischer T, Praus M, et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass: Impact of heparin management. Anesthesiology. 2002;97:837–41. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.